Legislation Introduced in Senate to Remove Prompt Pay Discounts from the Average Sales Price

10 May 2011 4:38 PM | Lori Aubrey (Administrator)
On April 5, Senator Pat Roberts (R-KS), along with Senator Debbie Stabenow (D-MI), introduced S. 733, legislation that would ensure more appropriate payments for cancer drugs by excluding prompt pay discounts extended to wholesalers from the manufacturer's average sales price (ASP).

Many practices are struggling because of this unfair calculation, which in many instances reimburses practices for rates that are lower than the purchase price of the drug. Some practices are being forced to send patients to the hospital where the drive and wait time for the patient are often longer. S. 733 would help address this access issue by removing the prompt pay discounts from the ASP, thereby ensuring that physicians are reimbursed adequately for the chemotherapy drugs they buy.

There will need to be significant support to move this bill forward, so send a message today to your Senators and ask them to cosponsor S. 733. Be sure to personalize the message to include details of how this issue is directly impacting your practice. The House version of the bill (H.R. 905) was introduced in March, so if you haven't already, please take a minute to send a message, using ASCO's ACT Network , to your Representative as well.


Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948

This website brought to you by:

Powered by Wild Apricot Membership Software